September 15, 2006—In a deal marking the first direct, Russian federal purchase of anti-retroviral HIV meds, British pharma company Glaxo Smith Kline announced plans today to provide the country with HIV meds Combivir, Epivir and Ziagen at a discounted price.  The deal should help Russia meet its goal of getting 15,000 positive people on treatment by the end of 2006.